A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
Clinical trial NCT00236691 · COMPLETED
Trial details
- NCT number
- NCT00236691
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1988-07-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.